Correction: Implementing Integrated Whole-Person Care for Chronic Pain: Lessons from VA’s Multisite wHOPE Study

• by Natalie Purcell, Liliana C. Moore, William C. Becker, Karen H. Seal

• November 5, 2026

FDA approves amivantamab for head and neck cancer

Accelerated approval follows a 42% response rate in 102 patients previously treated with chemotherapy and immunotherapy.

• by Mouj Hijazi

• November 6, 2026

• 3 min

Rosacea and IBS show bidirectional association

A nationwide Korean cohort study finds 30% higher IBS and 61% higher rosacea hazards, with stronger associations among men.

• by Andrea Surnit

• November 3, 2026

• 4 min

PET/MRI may reveal MRI-occult inflammation

In a rare anti-vimentin encephalitis case, molecular imaging detected abnormalities that declined alongside neurologic improvement following immunotherapy.

• by Andrea Surnit

• October 28, 2026

• 4 min